First Financial Equity Corporation’s Pfizer PFE Stock Holding History

First Financial Equity Corporation’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$2.02M	Buy	+62,223	New	+$1.96M	0.35%	89

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Financial Equity Corporation's PFE Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Pfizer (PFE) in Q1 2017: 62,223 shares worth $2.02M. The stake represents 0.35% of the portfolio and ranks #89 among its holdings.

2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

First Financial Equity Corporation held 62,223 shares of Pfizer worth $2.02M as of Q1 2017.
Pfizer was a new First Financial Equity Corporation position in Q1 2017.
Pfizer made up 0.35% of First Financial Equity Corporation's portfolio in Q1 2017, its #89 holding.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.